Compounded GLP-1s vs. 'Gray Market'?

Hong Kong Yanpep International
BrookDaily

BrookDaily

Member
Hey everyone,

I've been using a compounded version of tirz for a few months now and the results have been pretty great. But with the whole situation around multi-dose vials and patents, I'm a little worried about whether it will still be available.

I really want to stick with a doctor and dietitian, but I'm trying to avoid paying crazy high prices.

Has anyone had experience with getting compounded or 'gray market' versions from other sources? And if so, how did you discuss it with your doc?

Thanks!
 
I just told my doctor that I get my compound meds from an online pharmacy. We already talked about how the branded drugs were too expensive, so she knew I would go that route. I just didn't say that *I* was the compounding pharmacist. LOL
 
I also want my PCP to oversee my tirz use, and to have it documented in my medical history. But, I actually haven't told her about where I get it from. She keeps sending scripts to that specific pharmacy and I just ignore their texts. 😂 When she asks if I require a refill, I say I don't. 🙃 Probably not ideal, but it's working for the moment.
 
I told my doc I initially used tirz from a telehealth provider. Then I mentioned I'd switched to compounded reta. He upgraded my blood tests (I am on TRT) and keeps an eye on things.
 
To Patient_Mango229: Some patients do find Mounjaro more effective for weight loss than Ozempic. Mounjaro works on both GLP-1 and GIP receptors, potentially leading to greater benefits. However, side effects can vary. Discuss thoroughly with your doctor.
 
I've been a really slow loser on Ozempic. Like, maybe 10 pounds in four months. It's discouraging, but I keep telling myself slow progress is still progress. Seeing stories like this give me hope!
 
Tirz-Mode said:
He upgraded my blood tests (I am on TRT) and keeps an eye on things.
Click to expand...
That's the goal! I want my doc to be aware and monitor my bloodwork, even if I'm not getting the meds directly through her. It's about harm reduction and being responsible.
 
The legal landscape for self-managed GLP-1 use is genuinely murky and enforcement context varies widely by jurisdiction. People who think they're in a clear safe space and people who think they're taking massive risk are often looking at the same situation through very different lenses.
 
Mislabeling and mix-ups in unregulated supply chains are real and documented - visual identifiers like cap color aren't reliable enough on their own when the product isn't pharmaceutically manufactured and QC-verified. That's a structural risk that exists regardless of which specific vendor is involved.
 
You must log in or register to reply here.
Back
Top